The American Thrombosis and Hemostasis Network (ATHN) is the steward of extensive hemostasis and thrombosis data and analytic resources. The ATHN Affiliate Network consists of over 145 health care entities providing programs and services to…
Navigating the Emergency Room
Speaker(s): Dr. Lynn Malec
You will likely need to visit an emergency room at some point in you or your loved one's inhibitor journey. While those visits can't be foreseen, patients and…
FOR IMMEDIATE RELEASE
Ilana Ostrin
Senior Director of Public Relations and Communications
iostrin@hemophilia.org
212-328-3769 …
Pfizer and Sangamo have announced that recruitment has re-opened for the phase 3 AFFINE study for the investigational gene therapy giroctocogene fitelparvovec. This clinical study is evaluating the efficacy and safety of a single infusion of…
Parental perspectives on gene therapy for children with haemophilia: The Exigency Study
Speaker(s): Kate Khair, PhD
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend…
Genetic Counseling for Ultra-Rare Bleeding Disorders
Speaker(s): Tahnee Causey, MS, CGC
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the latest…
What's At Stake With The Upcoming Elections
Speaker(s): NHF Advocacy Team
NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the latest in research,…
Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A
Speaker(s): Dr. Robert Klamroth
NHF's Wednesday Webinars are a free education series open to providers and community…